- Home
- ORGO vs AVK Comparison
ORGO vs AVK Comparison
Compare ORGO & AVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- AVK
- Stock Information
- Founded
- ORGO 1985
- AVK 2003
- Country
- ORGO United States
- AVK United States
- Employees
- ORGO N/A
- AVK N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- AVK Trusts Except Educational Religious and Charitable
- Sector
- ORGO Health Care
- AVK Finance
- Exchange
- ORGO Nasdaq
- AVK Nasdaq
- Market Cap
- ORGO 620.3M
- AVK 561.1M
- IPO Year
- ORGO N/A
- AVK N/A
- Fundamental
- Price
- ORGO $4.07
- AVK $12.90
- Analyst Decision
- ORGO Buy
- AVK
- Analyst Count
- ORGO 3
- AVK 0
- Target Price
- ORGO $7.33
- AVK N/A
- AVG Volume (30 Days)
- ORGO 765.7K
- AVK 112.9K
- Earning Date
- ORGO 11-06-2025
- AVK 01-01-0001
- Dividend Yield
- ORGO N/A
- AVK 11.85%
- EPS Growth
- ORGO N/A
- AVK N/A
- EPS
- ORGO N/A
- AVK N/A
- Revenue
- ORGO $429,531,000.00
- AVK N/A
- Revenue This Year
- ORGO $2.51
- AVK N/A
- Revenue Next Year
- ORGO $25.45
- AVK N/A
- P/E Ratio
- ORGO N/A
- AVK N/A
- Revenue Growth
- ORGO N/A
- AVK N/A
- 52 Week Low
- ORGO $2.61
- AVK $9.24
- 52 Week High
- ORGO $6.71
- AVK $12.16
- Technical
- Relative Strength Index (RSI)
- ORGO 40.27
- AVK 56.94
- Support Level
- ORGO $3.84
- AVK $12.77
- Resistance Level
- ORGO $4.40
- AVK $13.10
- Average True Range (ATR)
- ORGO 0.22
- AVK 0.14
- MACD
- ORGO -0.03
- AVK 0.00
- Stochastic Oscillator
- ORGO 26.79
- AVK 58.18
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About AVK Advent Convertible and Income Fund
Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.